Cadila Healthcare Ltd. is a part of Zydus Group, a leading healthcare group of India. The company provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients, biological, vaccines, diagnostics, herbals and animal healthcare to cosmetics. Zydus Cadila’s strategic focus has been on fast growing therapeutic segments such as cardiovascular, gastrointestinal, pain management, biological, anti-infective, neuropsychiatry and preventives. Zydus Cadila has a global presence in 40 countries worldwide Zydus Healthcare (USA) LLC – our Subsidiary for bulk drug (API) operations in US and Zydus Pharmaceutical USA Inc. caters to the world’s largest generic market. Zydus France SAS, spearheads Zydus Group’s operations in France. Zydus Healthcare SA Pty Ltd. Is our wholly-owned subsidiary in South Africa. Lastly, we have acquired Nikkho in Brazil.